Eli Lilly | LLY - Sales Revenues

Eli Lilly And reported $7.3B in Sales Revenues for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbott ABT:US USD 10.09B 319M
Abbvie ABBV:US USD 15.12B 309M
ALKERMES ALKS:US USD 304.67M 52.32M
Amgen AMGN:US USD 6.84B 187M
AstraZeneca AZN:LN USD 11.21B 225M
Astrazeneca AZN:US USD 11.21B 225M
Baxter International BAX:US USD 3.89B 114M
Biogen BIIB:US USD 2.54B 35.5M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Catalent CTLT:US USD 1.15B 127M
Drreddys Laboratories RDY:US INR 67.7B 4.64B
Eli Lilly And LLY:US USD 7.3B 360.2M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Glaxosmithkline GSK:US GBP 7.38B 453M
Johnson & Johnson JNJ:US USD 23.71B 85M
Lannett LCI:US USD 80.89M 5.82M
Merk MRK:US USD 13.83B 1.13B
Neurocrine Biosciences NBIX:US USD 412M 24.1M
Novartis NOVN:VX USD 13B 159M
Novartis NVS:US USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B
Prestige Brands PBH:US USD 275.52M 13.75M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Teva Pharmaceutical Industries TEVA:US USD 3.88B 289M
Zoetis ZTS:US USD 2.04B 38M